All companies
DSM-Firmenich AG logo

What smart money is saying about DSM-Firmenich AGSwitzerland flag

DSFIR.AS · Consumer Defensive · Household & Personal Products · Market cap $18.42B

3 funds in our archive have pitched DSM-Firmenich AG — most recently Emerald Focused Equity Strategy in December 2025.

Company profile

DSM-Firmenich AG, a science-based company, engages in beauty, health, and nutrition businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Perfumery & Beauty; Animal Nutrition & Health (ANH); Health, Nutrition & Care (HNC); and Food & Beverage segments. The Perfumery & Beauty offers perfumery and aroma ingredients. The Animal Nutrition & Health segment offers essential products, including vitamins, premixes, and carotenoids; performance solutions, such as enzymes, microbes, and eubiotics; precision services comprising support with data analysis to measure animal health and environmental footprint on farm level and feed safety; and methane reducing feed additive for ruminants. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, personal care and aroma, and biomedical materials markets. It offers vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics and prebiotics, active pharmaceutical ingredients, and sunscreen filters, as well as a range of biomedical solutions; premix, market-ready solutions, and personalized nutrition solutions; and regulatory affairs and formulation expertise, and customized solutions. The Food & Beverage segment provides ingredients and solutions for use in a range of food products, such as dairy; bakery, cereals, and bars; savory food; beverages and brewing; confectionery and fruit; plant-based meat and fish alternatives; and petfood. The company was founded in 1902 and is headquartered in Kaiseraugst, Switzerland.

Fund coverage · 3 theses

  • Emerald Focused Equity Strategy
    December 2025

    DSM-Firmenich is a leading ingredients company with high switching costs, synergy delivery, structural beauty and nutrition tailwinds, and an attractive relative valuation.

    Read the full thesis
  • Bronte Capital
    September 2025

    DSM-Firmenich is undervalued at 1.6x EV/sales with structurally high-margin perfumery and fragrance segments, strong management and minimal debt.

    Read the full thesis
  • Aristotle Global Equity
    December 2024

    DSM-Firmenich is well-positioned for future growth despite recent challenges, leveraging its merger synergies, divestitures, and strong customer relationships to enhance profitability and market share.

    Read the full thesis

Read every full thesis on DSM-Firmenich AG

Unlock all 3 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.

View plans